Is Interleukin-6 Blockade a Viable Strategy to Prevent Progression of Acute Respiratory Distress Syndrome in non-COVID Viral Pneumonia?
Clinical Immunology Communications
; 2023.
Article
in English
| ScienceDirect | ID: covidwho-2234083
Full text:
Available
Collection:
Databases of international organizations
Database:
ScienceDirect
Language:
English
Journal:
Clinical Immunology Communications
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS